Skip to main content
Journal cover image

Clinical Outcomes of Older Kidney Transplant Recipients.

Publication ,  Journal Article
Salas, MAP; Rodriguez-Abreu, RD; Amaechi, P; Rao, V; Soliman, K; Taber, D
Published in: Am J Med Sci
August 2021

BACKGROUND: Older kidney transplant recipients (OKTR) are vulnerable to infections and AKI, often prompting hospitalization. This study elucidates etiology of hospitalizations, AKI, and outcomes in OKTR. METHODS: Retrospective study of 500 patients age ≥ 60, who underwent kidney transplantation from 2005-2015. Demographic, transplant, and outcomes data were collected. RESULTS: OKTR had mean age 66 years; 59% males and 50% African Americans. 62% had at least one hospitalization post-transplant. Predictors of hospitalization were DGF, DM, panel reactive antibodies (PRA), dialysis duration. Hospitalization was mostly due to infection and surgical complications. Average length of stay was 6.4 days. OKTR with at least one hospitalization had 84% higher risk for graft loss (p=0.001). 56% of older kidney transplant recipients had at least one AKI episode post-transplant. Predictors of AKI included DGF, older, African American donor, and tacrolimus variability. The most common etiologies for AKI were infection, dehydration, and GI complications. OKTR with at least one AKI episode had 2.6-fold higher risk for graft loss (p<0.001). CONCLUSIONS: Post-transplant hospitalization and AKI in OKTR significantly impact graft survival. Addressing comorbidities and risks in the pre-transplant and outpatient setting may help alleviate burden of hospitalization and risk of AKI in OKTR and improve graft outcomes.

Duke Scholars

Published In

Am J Med Sci

DOI

EISSN

1538-2990

Publication Date

August 2021

Volume

362

Issue

2

Start / End Page

130 / 134

Location

United States

Related Subject Headings

  • Transplant Recipients
  • Tacrolimus
  • Risk Factors
  • Retrospective Studies
  • Odds Ratio
  • Middle Aged
  • Male
  • Kidney Transplantation
  • Immunosuppressive Agents
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Salas, M. A. P., Rodriguez-Abreu, R. D., Amaechi, P., Rao, V., Soliman, K., & Taber, D. (2021). Clinical Outcomes of Older Kidney Transplant Recipients. Am J Med Sci, 362(2), 130–134. https://doi.org/10.1016/j.amjms.2021.02.017
Salas, Maria Aurora Posadas, Rafael David Rodriguez-Abreu, Prince Amaechi, Vinaya Rao, Karim Soliman, and David Taber. “Clinical Outcomes of Older Kidney Transplant Recipients.Am J Med Sci 362, no. 2 (August 2021): 130–34. https://doi.org/10.1016/j.amjms.2021.02.017.
Salas MAP, Rodriguez-Abreu RD, Amaechi P, Rao V, Soliman K, Taber D. Clinical Outcomes of Older Kidney Transplant Recipients. Am J Med Sci. 2021 Aug;362(2):130–4.
Salas, Maria Aurora Posadas, et al. “Clinical Outcomes of Older Kidney Transplant Recipients.Am J Med Sci, vol. 362, no. 2, Aug. 2021, pp. 130–34. Pubmed, doi:10.1016/j.amjms.2021.02.017.
Salas MAP, Rodriguez-Abreu RD, Amaechi P, Rao V, Soliman K, Taber D. Clinical Outcomes of Older Kidney Transplant Recipients. Am J Med Sci. 2021 Aug;362(2):130–134.
Journal cover image

Published In

Am J Med Sci

DOI

EISSN

1538-2990

Publication Date

August 2021

Volume

362

Issue

2

Start / End Page

130 / 134

Location

United States

Related Subject Headings

  • Transplant Recipients
  • Tacrolimus
  • Risk Factors
  • Retrospective Studies
  • Odds Ratio
  • Middle Aged
  • Male
  • Kidney Transplantation
  • Immunosuppressive Agents
  • Humans